Irvine-based ChromaDex Corp. has been awarded a $500,000 Phase II Small Business Innovation Research Grant from the National Science Foundation to further the company’s development of plant-based antioxidants.
Photo by photo-john – Fotolia
Anthocyanins occur in plant pigments, and they help protect people from oxidative stress and manage blood glucose levels. ChromaDex aims to improve technology for the manufacturing of anthocyanins, as there has been a growth in demand for more natural ingredients in food and cosmetics, and anthocyanins can be implemented in both.
"We are pleased the NSF is continuing its support as we enter the final stretch in readying our AnthoPure technology for market," said Frank Jaksch, co-founder and chief executive officer at ChromaDex. "Less than half of NSF Phase I grants are awarded a Phase II, so receiving this award validates that we are driving this technology toward commercialization."
Ceradyne acquires Seattle-based VIOX Corp.
Centiuum forms joint venture with South Korean firm
Paciolan software set to be used on Facebook